A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

NCT01424813 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo MDPI
DRUG: Albuterol MDPI

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.